Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
Gastrointestinal Therapeutics
... at a CAGR of 5.1% over the analysis period 2023-2030. Crohn`s Disease End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$19.0 Billion by the end ... Read More
-
Gastroparesis Drugs
... at a CAGR of 4.7% over the analysis period 2023-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the end ... Read More
-
Short Bowel Syndrome (SBS)
... reach US$6.4 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2023-2030. GLP-2 Drugs, one of the segments analyzed in the report, is expected to record a 23.3% CAGR and reach ... Read More
-
Gastrointestinal Stents
... at a CAGR of 5.9% over the analysis period 2023-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of ... Read More
-
Gastrointestinal Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Forecast to 2029
... to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of 6.1% from 2024 to 2029. The market for gastroenterology and gastrointestinal products is driven by several factors, such ... Read More
-
United States In-Vitro Diagnostics (IVD) Market, By Product and Services (Reagents & Kits, Instruments, Software & Services); By Technique (Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Immunodiagnostics, Hematology, Others); By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others); By End User (Standalone Laboratories, Hospitals, Academic & Medical Schools, Point of Care (PoC), Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 United States In-Vitro Diagnostics (IVD) ... Read More
-
2024 Global H. Pylori Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Global gastroenterology market growth is ... Read More
-
Dyspepsia Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine
... on global dyspepsia market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dyspepsia market by segmenting the ... Read More
-
Antacids
... of 2.2% over the analysis period 2023-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Global Gastric Cancer Market (2024 Edition): Analysis By Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), By Therapy, By Drug Class, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Gastric Cancer Market (2024 Edition)” which provides a Gastric Cancer/Gastroesophageal Junction Cancer analysis of the Global Gastric Cancer industry in terms of market segmentation By Indication (Gastric Cancer/Gastroesophageal Junction ... Read More
-
Ulcerative Colitis Therapeutics
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by ... Read More
-
Helicobacter Pylori Infections - Market Insight, Epidemiology And Market Forecast - 2034
... variability of the H. pylori strains, and antibiotic usage. The H. pylori infection market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of H. pylori infection in the 7MM ... Read More
-
Digestive Enzyme Supplements
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Additional Supplements Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.2 Billion ... Read More
-
Global Digestive Health Supplements Market 2024-2028
... forecast period. The report on the digestive health supplements market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Liquid Dietary Supplements Market Research Report Information by Ingredients (Vitamins, Minerals, Proteins and Amino acids, and Other Ingredients), Application (Bone Disorders, Cardiac Health Gastrointestinal Health, Sports Nutrition, Weight Management, Other Applications), By Distribution Channel (Online, Offline), And By Region (North America, Europe, Asia-Pacific, Rest of the world) – Industry Forecast Till 2030
... Offline), And By Region (North America, Europe, Asia-Pacific, Rest of the world) – Industry Forecast Till 2030 The industry for liquid dietary supplements is expected to expand at a compound annual growth rate (CAGR) of ... Read More
-
Animal Gastroesophageal Reflux Disease Market Size, Share & Trends Analysis Report By Product, By Animal (Companion, Livestock), By Mode, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
... Size & Trends The global animal gastroesophageal reflux disease market size was valued at USD 1.82 billion in 2023 and is expected to grow at a CAGR of 7.8% from 2024 to 2030. The market ... Read More
-
Global Botanical Supplements Market Size Study, by Source (Flowers, Fruits, Leaves, Roots, Seeds, Stems), by Form (Capsules, Gummies, Liquid, Powder, Tablets), by Age Group (0-10 Years, 11-20 Years, 21-45 Years, 46-60 Years, 60 Years and above), by Application (Anti-Cancer, Bone & Joint Health, Cardiac Health, Diabetes, Energy & Weight Management, Gastrointestinal Health, General Health, Immunity), by Distribution Channel (Offline, Online) and Regional Forecasts 2022-2032
... above), by Application (Anti-Cancer, Bone & Joint Health, Cardiac Health, Diabetes, Energy & Weight Management, Gastrointestinal Health, General Health, Immunity), by Distribution Channel (Offline, Online) and Regional Forecasts 2022-2032 Global Botanical Supplements Market is valued ... Read More
-
Global Malabsorption Syndrome Market 2024-2028
... report on the malabsorption syndrome market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Gastrointestinal Diseases Therapeutics Market 2024-2028
... gastrointestinal diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Gastrointestinal Bleeding Treatment Market 2024-2028
... gastrointestinal bleeding treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
... Inflammatory Bowel Disease Treatment Market Growth & Trends The global inflammatory bowel disease treatment market size is expected to reach USD 27.73 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, ... Read More
-
Global Antacids Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Constipation Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... onset of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for constipation treatment, thereby impacting the market growth. However, at the onset, ... Read More
-
Inflammatory Bowel Disease (IBD) Therapeutics
... is expected to reach US$32.8 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. TNF inhibitors, one of the segments analyzed in the report, is expected to record a 5.9% ... Read More